Beruflich Dokumente
Kultur Dokumente
1. Purpose:-
The Purpose of this SOP is to provide documented evidence that methods, process, techniques and other
pharmaceutical product development activities (developed by R&D) can be reproduced consistently against a set
of predefined specifications & To elucidate necessary information to transfer technology from R&D to actual
manufacturing by sorting out information obtained during R&D work.
2. Scope:-
This procedure applies to complete technology transfer including transfer of process, method, knowledge from
development stage to manufacturer site of product within Medizan Laboratories (Pvt.) Ltd.
3. Responsibilities:-
c. Any technology transfer will be managed by a team comprising members from different department; R&D,
QC, Production, Warehouse, QA, Engineering etc. who involved in the dispensing of material,
manufacturing, packing, analysis. A clear responsibilities shall be define in technology transfer protocol.
d. A formal agreement between both parties will be made which specifies clear responsibilities before, during
and after technology transfer (in case of outside transfer).
e. A transparency between both parties shall be maintain during technology transfer because any lack of
transparency may lead to ineffective transfer of technology.
f. For the successful technology transfer following general principal and requirement should be met;
Project plan shall be encompass the quality aspects of the project and plan should be based on the
quality risk management principles to identify all the hazards and their mitigation plan.
A comprehensive technical & regulatory gap assessment between sending site and receiving site
shall be done before technology transfer.
During technical and regulatory gap assessment following points shall be considered but not limited
to:
Equipment equivalence of sending site and receiving site w.r.t. capacity, working principle shall be
consider during risk assessment, if both site equipment are different in terms of capacity and
working principle then adequate risk mitigation plan shall be proposed like process optimization,
critical control parameter identification & process validation with receiving site equipment, batch
size determination based on the equipment capacity etc.
Area classification of both sending site and receiving site shall be verified for its equivalence.
Classification of both site where product manufactured should be same and qualified against a
predefined standard and raw material and product requirement like relative humidity, temperature,
non-viable and viable counts, differential pressure etc.
Water quality (raw water, purified water, water for injection, pure steam) of sending site and
receiving site shall be assess for its equivalence. Water is the main source of microbial
proliferation so microbial limit should not be more than finished goods specification of product
and water system should be qualified against pre-defined specification before its use.
Availability of all other critical utilities shall be ensure before technology transfer. All the critical
utilities and its capacity like pressure, purity, piping and design should match with the sending site
critical utilities used in the manufacturing/ packaging of respective product.
__________________________________________________________________________________
Controlled Copy : Do not Duplicate Copy# Page 2 of 19
Department Document No.
Medizan Laboratories (Pvt.) Ltd. R&D ML – RND – SOP - XXX
Effective Date Next Revision Date
Standard Operating Procedure 01-12-2018 01-01-2018
Revision Date Revision No.
Technology Transfer Procedure 01-12-2018 00
Prepared by: Sign with Date Reviewed by: Sign with Date Checked by: Sign with Date Approved by: Sign with Date
h. In case of new product development and transfer to the manufacturing site from R&D analytical method to be
developed by R&D and suitability of that method shall be verified at manufacturing site quality control
laboratory. In case of technology transfer from one manufacturing site to another manufacturing site responsible
person of sending site quality control shall be transferred method at receiving site and trained to all the personnel.
Analytical method transfer activity shall be done through approved protocol and method transfer report shall be
approved by both parties (sending site and receiving site) then only analytical method transfer will be treated as
confirm
j. Technology transfer shall be performed through an approved protocol which consist following but not limited to;
Objective: A clear objective in the protocol is required which state that this protocol is applicable for the
technology transfer of “Product, Dose” from “sending site with complete address” to “receiving site with
complete address- facility”
Quality is designed based on basic data concerning efficacy and safety obtained from various
studies. Various standards for manufacturing and tests will be established in process during
reviewing factory production and will be upgraded to the quality of product and the actual
production will be started. The technology transfer consists of actions taken in these flows of
development to realize the quality as designed during the development stage. The technology
transfer processes are classified broadly as mentioned below:
__________________________________________________________________________________
Controlled Copy : Do not Duplicate Copy# Page 3 of 19
Department Document No.
Medizan Laboratories (Pvt.) Ltd. R&D ML – RND – SOP - XXX
Effective Date Next Revision Date
Standard Operating Procedure 01-12-2018 01-01-2018
Revision Date Revision No.
Technology Transfer Procedure 01-12-2018 00
Prepared by: Sign with Date Reviewed by: Sign with Date Checked by: Sign with Date Approved by: Sign with Date
__________________________________________________________________________________
Controlled Copy : Do not Duplicate Copy# Page 4 of 19
Department Document No.
Medizan Laboratories (Pvt.) Ltd. R&D ML – RND – SOP - XXX
Effective Date Next Revision Date
Standard Operating Procedure 01-12-2018 01-01-2018
Revision Date Revision No.
Technology Transfer Procedure 01-12-2018 00
Prepared by: Sign with Date Reviewed by: Sign with Date Checked by: Sign with Date Approved by: Sign with Date
__________________________________________________________________________________
Controlled Copy : Do not Duplicate Copy# Page 5 of 19
Department Document No.
Medizan Laboratories (Pvt.) Ltd. R&D ML – RND – SOP - XXX
Effective Date Next Revision Date
Standard Operating Procedure 01-12-2018 01-01-2018
Revision Date Revision No.
Technology Transfer Procedure 01-12-2018 00
Prepared by: Sign with Date Reviewed by: Sign with Date Checked by: Sign with Date Approved by: Sign with Date
__________________________________________________________________________________
Controlled Copy : Do not Duplicate Copy# Page 6 of 19
Department Document No.
Medizan Laboratories (Pvt.) Ltd. R&D ML – RND – SOP - XXX
Effective Date Next Revision Date
Standard Operating Procedure 01-12-2018 01-01-2018
Revision Date Revision No.
Technology Transfer Procedure 01-12-2018 00
Prepared by: Sign with Date Reviewed by: Sign with Date Checked by: Sign with Date Approved by: Sign with Date
1.0 kg
1.0 kg
__________________________________________________________________________________
Controlled Copy : Do not Duplicate Copy# Page 7 of 19
Department Document No.
Medizan Laboratories (Pvt.) Ltd. R&D ML – RND – SOP - XXX
Effective Date Next Revision Date
Standard Operating Procedure 01-12-2018 01-01-2018
Revision Date Revision No.
Technology Transfer Procedure 01-12-2018 00
Prepared by: Sign with Date Reviewed by: Sign with Date Checked by: Sign with Date Approved by: Sign with Date
__________________________________________________________________________________
Controlled Copy : Do not Duplicate Copy# Page 8 of 19
Department Document No.
Medizan Laboratories (Pvt.) Ltd. R&D ML – RND – SOP - XXX
Effective Date Next Revision Date
Standard Operating Procedure 01-12-2018 01-01-2018
Revision Date Revision No.
Technology Transfer Procedure 01-12-2018 00
Prepared by: Sign with Date Reviewed by: Sign with Date Checked by: Sign with Date Approved by: Sign with Date
__________________________________________________________________________________
Controlled Copy : Do not Duplicate Copy# Page 9 of 19
Department Document No.
Medizan Laboratories (Pvt.) Ltd. R&D ML – RND – SOP - XXX
Effective Date Next Revision Date
Standard Operating Procedure 01-12-2018 01-01-2018
Revision Date Revision No.
Technology Transfer Procedure 01-12-2018 00
Prepared by: Sign with Date Reviewed by: Sign with Date Checked by: Sign with Date Approved by: Sign with Date
__________________________________________________________________________________
Controlled Copy : Do not Duplicate Copy# Page 10 of 19
Department Document No.
Medizan Laboratories (Pvt.) Ltd. R&D ML – RND – SOP - XXX
Effective Date Next Revision Date
Standard Operating Procedure 01-12-2018 01-01-2018
Revision Date Revision No.
Technology Transfer Procedure 01-12-2018 00
Prepared by: Sign with Date Reviewed by: Sign with Date Checked by: Sign with Date Approved by: Sign with Date
S. No. Batch No. Manufacturing Date Batch Size Yield Usage of product Purity
1.0 kg
1.0 kg
__________________________________________________________________________________
Controlled Copy : Do not Duplicate Copy# Page 11 of 19
Department Document No.
Medizan Laboratories (Pvt.) Ltd. R&D ML – RND – SOP - XXX
Effective Date Next Revision Date
Standard Operating Procedure 01-12-2018 01-01-2018
Revision Date Revision No.
Technology Transfer Procedure 01-12-2018 00
Prepared by: Sign with Date Reviewed by: Sign with Date Checked by: Sign with Date Approved by: Sign with Date
S. No. Sample ID Batch No. Manufacturing Date Expiry Date Content (%)
In-house sample
Market sample-1
Market sample-2
__________________________________________________________________________________
Controlled Copy : Do not Duplicate Copy# Page 12 of 19
Department Document No.
Medizan Laboratories (Pvt.) Ltd. R&D ML – RND – SOP - XXX
Effective Date Next Revision Date
Standard Operating Procedure 01-12-2018 01-01-2018
Revision Date Revision No.
Technology Transfer Procedure 01-12-2018 00
Prepared by: Sign with Date Reviewed by: Sign with Date Checked by: Sign with Date Approved by: Sign with Date
Affix
Chromatogram/UV Spectrum of (Blank)
Affix
Chromatogram/UV Spectrum of (Standard)
Affix
Chromatogram/UV Spectrum of (In-house Sample)
Affix
Chromatogram/UV Spectrum of (Market Sample-01)
Affix
Chromatogram/UV Spectrum of (Market Sample-02)
__________________________________________________________________________________
Controlled Copy : Do not Duplicate Copy# Page 13 of 19
Department Document No.
Medizan Laboratories (Pvt.) Ltd. R&D ML – RND – SOP - XXX
Effective Date Next Revision Date
Standard Operating Procedure 01-12-2018 01-01-2018
Revision Date Revision No.
Technology Transfer Procedure 01-12-2018 00
Prepared by: Sign with Date Reviewed by: Sign with Date Checked by: Sign with Date Approved by: Sign with Date
__________________________________________________________________________________
Controlled Copy : Do not Duplicate Copy# Page 14 of 19
7.0 PRODUCT SPECIFICATIONS:
__________________________________________________________________________________
Controlled Copy : Do not Duplicate Copy# Page 0 of 19
9.0 CHECKLIST OF DOCUMENTS PROVIDE DURING TECHNOLOGY TRANSFER
04 Master Formulation
05 Manufacturing Details
07 Stability Reports
__________________________________________________________________________________
Controlled Copy : Do not Duplicate Copy# Page 1 of 19
08 List of QC Equipment Used in Testing
11 Scale Up Studies
16 Training Record
20 Others.____________________________________
10. References:-
5.1 Scale-up & Technology Transfer as a Part of Pharmaceutical Quality Systems
https://www.fda.gov/downloads/drugs/developmentapprovalprocess/manufacturing/ucm
291604.pdf
__________________________________________________________________________________
Controlled Copy : Do not Duplicate Copy# Page 2 of 19
11. Record:-
12. Distribution:-
13. History:-
__________________________________________________________________________________
Controlled Copy : Do not Duplicate Copy# Page 3 of 19